American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$311M |
| 2 |
Humana
HUM
|
+$270M |
| 3 |
Meta Platforms (Facebook)
META
|
+$256M |
| 4 |
Colgate-Palmolive
CL
|
+$163M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$160M |
Top Sells
| 1 |
Amazon
AMZN
|
+$653M |
| 2 |
Microsoft
MSFT
|
+$614M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$348M |
| 4 |
L3Harris
LHX
|
+$242M |
| 5 |
Idexx Laboratories
IDXX
|
+$238M |
Sector Composition
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Reinsurance Group of America
RGA
$12.7B
| $206M | 0.16% |
1,552,726
-106,211
| -6% | -$14.1M |
|
152
Champion Homes, Inc.
SKY
$4.35B
| $203M | 0.16% |
2,697,094
-43,071
| -2% | -$3.24M |
|
153
Charles Schwab
SCHW
$170B
| $201M | 0.16% |
3,835,336
+1,246,652
| +48% | +$65.3M |
|
|
BDXB
154
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $199M | 0.16% |
3,997,703
+38,657
| +1% | +$1.92M |
|
155
Amcor
AMCR
$18.9B
| $199M | 0.16% |
17,444,100
+3,840,250
| +28% | +$43.7M |
|
156
Manhattan Associates
MANH
$13.3B
| $198M | 0.16% |
1,280,782
+31,104
| +2% | +$4.81M |
|
157
Cognex
CGNX
$7.49B
| $196M | 0.15% |
3,999,399
+197,016
| +5% | +$9.64M |
|
158
Healthpeak Properties
DOC
$12.7B
| $195M | 0.15% |
8,873,653
-2,046,876
| -19% | -$45M |
|
159
Cintas
CTAS
$81.7B
| $191M | 0.15% |
1,654,956
-1,414,808
| -46% | -$164M |
|
160
Union Pacific
UNP
$129B
| $189M | 0.15% |
940,967
+26,852
| +3% | +$5.4M |
|
161
TotalEnergies
TTE
$133B
| $189M | 0.15% |
3,193,093
+82,020
| +3% | +$4.84M |
|
162
Gilead Sciences
GILD
$144B
| $188M | 0.15% |
2,271,017
+1,106,924
| +95% | +$91.8M |
|
163
TSMC
TSM
$1.28T
| $188M | 0.15% |
2,017,562
+187,522
| +10% | +$17.4M |
|
164
Becton Dickinson
BDX
$54.9B
| $187M | 0.15% |
753,726
-45,271
| -6% | -$11.2M |
|
165
Unilever
UL
$157B
| $186M | 0.15% |
3,581,381
-50,349
| -1% | -$2.61M |
|
166
Waters Corp
WAT
$18.4B
| $184M | 0.15% |
594,506
+53,204
| +10% | +$16.5M |
|
167
Cencora
COR
$57.7B
| $184M | 0.14% |
1,148,135
+75,469
| +7% | +$12.1M |
|
168
Regency Centers
REG
$13.3B
| $183M | 0.14% |
2,992,984
+54,720
| +2% | +$3.35M |
|
|
HES
169
DELISTED
Hess
HES
| $183M | 0.14% |
1,383,889
+35,846
| +3% | +$4.74M |
|
170
Palo Alto Networks
PANW
$132B
| $181M | 0.14% |
1,815,382
+40,778
| +2% | +$4.07M |
|
171
Ameriprise Financial
AMP
$46.4B
| $179M | 0.14% |
585,976
-43,781
| -7% | -$13.4M |
|
172
Labcorp
LH
$23B
| $178M | 0.14% |
902,483
+58,300
| +7% | +$11.5M |
|
173
FMC
FMC
$4.73B
| $178M | 0.14% |
1,464,466
-251,967
| -15% | -$30.6M |
|
174
Coherent
COHR
$15.4B
| $176M | 0.14% |
4,624,897
-5,270
| -0.1% | -$201K |
|
175
Aflac
AFL
$56.9B
| $176M | 0.14% |
2,722,423
-97,062
| -3% | -$6.26M |
|